A fast-growing, cloud-native SaaS company headquartered in Bangalore with offices in the US, UK, and Europe, specializing in pharmacovigilance (PV) and clinical trial IT solutions for the global life sciences industry. The company offers an all-in-one platform combining intake, case processing, regulatory submissions, and signal detection — reducing IT costs by up to 70% and time-to-compliance by 30%.
Founded in 2017, the company has a domain-specialized team of 65+ employees based in India and supports 100+ direct clients and over 160 end clients across more than 15 countries.
Core Platform Capabilities
- Unified PV database with AS2 Gateway
- Web, email, and MICC intake modules
- Case processing, autonarratives, signal detection
- E2B R2/R3 support and realtime analytics
- Integrated CTMS, EDC, eTMF, ePRO, IWRS, and eConsent modules
Differentiation
- AIpowered automations for case booking, triage, and processing
- Endtoend unified system (vs. fragmented tools in legacy stacks)
- Inbuilt regulatory compliance tools (e.g., submissions, reporting)
- Trusted by top 3 of India’s top 10 pharma companies
Strategic Footprint
- Strong presence in India, USA, UK, and broader Europe
- Embedded in global CROs and expanding via partnerships (e.g., Wipro, Persistent, Cognizant)
- Actively used across 250+ clinical studies
Vision
- 2025: AIled automation of pharmacovigilance workflows
- 2030: Become a global top10 PV IT provider capturing 30% market share
Currency: USD
Target Price / Revenue: TBD
Target Price / EBITDA: TBD
